Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

84.1K
Overview
84.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.5K
What is the Immune System?01:38

What is the Immune System?

128.1K
Overview
128.1K
Humoral Immune Responses01:36

Humoral Immune Responses

83.9K
Overview
83.9K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

110.9K
Overview
110.9K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

11.8K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2025
Same author

AI-driven reclassification of multiple sclerosis progression.

Nature medicine·2025
Same author

Targeting the neonatal Fc receptor (FcRn) is not beneficial in an animal model of chronic neuritis.

Immunologic research·2024
Same author

Prognostic factors for worsening and improvement in multiple sclerosis using a multistate model.

Multiple sclerosis (Houndmills, Basingstoke, England)·2024
Same author

Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.

Neurology·2024
Same author

A review of Bruton's tyrosine kinase inhibitors in multiple sclerosis.

Therapeutic advances in neurological disorders·2024
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
Same journal

Integrating sexual health into care for patients with cancer and chronic illness.

Nature reviews. Disease primers·2026
Same journal

Chronic graft-versus-host disease.

Nature reviews. Disease primers·2026
See all related articles

Related Experiment Video

Updated: Feb 4, 2026

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

3.3K

Immune-mediated neuropathies.

Bernd C Kieseier1, Emily K Mathey2, Claudia Sommer3

  • 1Department of Neurology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. bernd.kieseier@uni-duesseldorf.de.

Nature Reviews. Disease Primers
|October 13, 2018
PubMed
Summary
This summary is machine-generated.

Immune-mediated polyneuropathies, like Guillain-Barré syndrome, CIDP, and MMN, are complex autoimmune disorders. Advances in diagnosis and targeted therapies offer hope for better management of these challenging nerve conditions.

More Related Videos

Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy
14:54

Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy

Published on: November 29, 2015

9.1K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.0K

Related Experiment Videos

Last Updated: Feb 4, 2026

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

3.3K
Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy
14:54

Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy

Published on: November 29, 2015

9.1K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.0K

Area of Science:

  • Neurology
  • Immunology
  • Peripheral Nervous System Disorders

Background:

  • Immune-mediated polyneuropathies encompass a spectrum of disorders, including Guillain-Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), and multifocal motor neuropathy (MMN).
  • These conditions are generally believed to result from autoimmune attacks on peripheral nerve myelin or nodes of Ranvier, though specific autoantibodies are not identified for all subtypes.
  • The increasing number of identified subtypes complicates clinical diagnosis and treatment strategies.

Purpose of the Study:

  • To review the evolving landscape of immune-mediated polyneuropathies.
  • To highlight the diagnostic and therapeutic challenges associated with these conditions, particularly chronic variants like CIDP and MMN.
  • To discuss the potential impact of improved clinical criteria and disease-specific immunotherapies.

Main Methods:

  • Review of existing literature on immune-mediated polyneuropathies.
  • Analysis of diagnostic challenges and current treatment modalities.
  • Discussion of emerging therapeutic approaches.

Main Results:

  • The spectrum of immune-mediated polyneuropathies has expanded significantly over the past century.
  • Diagnosis remains complex due to numerous subtypes and unidentified autoantibodies in some cases.
  • Current treatments primarily involve immunotherapies like corticosteroids, IVIg, and plasma exchange.

Conclusions:

  • Advances in diagnostic criteria and the development of targeted immunotherapies are crucial for improving patient outcomes.
  • Enhanced understanding and treatment strategies are needed for disabling immune-mediated polyneuropathies.
  • Future research should focus on identifying specific autoantibodies and developing more personalized treatment options.